These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18080767)

  • 21. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression?
    Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
    Cancer; 1995 Mar; 75(6 Suppl):1527-33. PubMed ID: 7889486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth.
    Ghirardi M; Nascimbeni R; Villanacci V; Fontana MG; Di Betta E; Salerni B
    Eur Surg Res; 1999; 31(3):272-80. PubMed ID: 10352356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
    Takayama T; Miyanishi K; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Kogawa T; Abe T; Niitsu Y
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7 Suppl 1):S42-5. PubMed ID: 16012995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-catenin expression is altered in dysplastic and nondysplastic aberrant crypt foci of human colon.
    Mi B; Wang X; Bai Y; Gong W; Wang X; Geng Y; Wang J; Zhang H; Jiang B
    Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):294-300. PubMed ID: 19247180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease.
    Nascimbeni R; Villanacci V; Mariani PP; Di Betta E; Ghirardi M; Donato F; Salerni B
    Am J Surg Pathol; 1999 Oct; 23(10):1256-63. PubMed ID: 10524527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
    BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
    Gupta AK; Schoen RE
    Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.
    Ieda S; Watatani M; Yoshida T; Kuroda K; Inui H; Yasutomi M
    Surg Today; 1996; 26(4):230-5. PubMed ID: 8727942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
    Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
    Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.
    Suehiro Y; Hinoda Y
    Cancer Sci; 2008 Jun; 99(6):1071-6. PubMed ID: 18384435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.
    Roncucci L; Pedroni M; Vaccina F; Benatti P; Marzona L; De Pol A
    Cell Prolif; 2000 Feb; 33(1):1-18. PubMed ID: 10741640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of preneoplastic lesions as mucin-depleted foci in patients with sporadic colorectal cancer.
    Sakai E; Morioka T; Yamada E; Ohkubo H; Higurashi T; Hosono K; Endo H; Takahashi H; Takamatsu R; Cui C; Shiozawa M; Akaike M; Samura H; Nishimaki T; Nakajima A; Yoshimi N
    Cancer Sci; 2012 Jan; 103(1):144-9. PubMed ID: 22017323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo.
    Van Gijssel HE; Ohlson LC; Torndal UB; Mulder GJ; Eriksson LC; Porsch-Hällström I; Meerman JH
    Hepatology; 2000 Oct; 32(4 Pt 1):701-10. PubMed ID: 11003613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance and role of early-lesions in experimental colorectal carcinogenesis.
    Mori H; Hata K; Yamada Y; Kuno T; Hara A
    Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression.
    Thorup I
    Carcinogenesis; 1997 Mar; 18(3):465-72. PubMed ID: 9067543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interaction between p53 and MDM2 in human lung cancer cells].
    Rybárová S; Hodorová I; Vecanová J; Muri J; Mihalik J
    Klin Onkol; 2014; 27(1):33-7. PubMed ID: 24635435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.